Company intelligence / Profile preview

Micro Synbio

Beijing, Beijing, China
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

MicroSynbio, officially known as Beijing Micro-structure Factory, is a leading synthetic biology company specializing in the sustainable production of polyhydroxyalkanoates (PHA) and other high-value bio-based chemicals. Founded in 2021 by Professor Chen Guoqiang of Tsinghua University, the company utilizes a proprietary "Next-Generation Industrial Biotechnology" (NGIB) platform based on engineered halophilic bacteria (Halomonas). This platform enables open, continuous, and non-sterile fermentation, which significantly reduces energy consumption and production costs compared to traditional biomanufacturing methods. MicroSynbio's product portfolio includes various types of PHA for applications in biodegradable plastics, medical devices, and animal nutrition, as well as specialty chemicals like 3-hydroxybutyrate and ectoine. The company operates large-scale manufacturing facilities and has secured significant funding from major venture capital firms to scale its sustainable biomanufacturing solutions globally.

Therapeutic areas
Metabolic DisordersDermatologyOther
Modalities
BiologicSmall moleculeMicrobial therapy
Industry
Non-Drug Biotech
02

Partnerships

SinopecCOFCOTsinghua University

Beyond the preview

Go deeper on Micro Synbio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micro Synbio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call